• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

链阳性菌素RP 59500的两种成分在实验性心内膜炎心脏赘生物中的体内活性及渗透情况。

In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis.

作者信息

Fantin B, Leclercq R, Ottaviani M, Vallois J M, Maziere B, Duval J, Pocidalo J J, Carbon C

机构信息

Institut National de la Santé et de la Recherche Médicale, Hôpital Bichat, Université Paris, VII, France.

出版信息

Antimicrob Agents Chemother. 1994 Mar;38(3):432-7. doi: 10.1128/AAC.38.3.432.

DOI:10.1128/AAC.38.3.432
PMID:8203835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC284476/
Abstract

We evaluated the in vivo activity and the diffusion of radiolabelled RP 57669 (RPI) and RP 54476 (RPII), the two components of the injectable streptogramin RP 59500, alone or in combination, in aortic vegetations from experimental endocarditis in rabbits. RPI and RPII demonstrated in vitro bacteriostatic and bactericidal synergy against a clinical strain of Staphylococcus aureus resistant to methicillin and susceptible to erythromycin. In experimental staphylococcal endocarditis, RP 59500 was as effective as vancomycin and significantly more effective than RPI (P < 0.01) and RPII (P < 0.05). Autoradiography studies showed different patterns of distribution into cardiac vegetations infected with Streptococcus sanguis for [14C]RPI and [14C]RPII. [14C]RPI was homogeneously distributed throughout the vegetations whereas [14C]RPII showed a decreasing gradient of concentration between the periphery and the core of the vegetation, with an approximately 2:1 ratio. [14C]RPI diffused approximately 2 to 4 times more than [14C]RPII into the core of the vegetations. Since the injected ratio of RPI and RPII is 30:70 in RP 59500, the actual RPI:RPII ratio in the core of the vegetation may range from 0.8 to 1.7, a ratio which remains compatible with the in vivo synergism demonstrated between the two components.

摘要

我们评估了放射性标记的RP 57669(RPI)和RP 54476(RPII)这两种注射用链阳性菌素RP 59500的成分单独或联合使用时在兔实验性心内膜炎主动脉赘生物中的体内活性和扩散情况。RPI和RPII在体外对一株耐甲氧西林但对红霉素敏感的金黄色葡萄球菌临床菌株表现出抑菌和杀菌协同作用。在实验性葡萄球菌性心内膜炎中,RP 59500与万古霉素一样有效,且显著比RPI(P < 0.01)和RPII(P < 0.05)更有效。放射自显影研究显示,[14C]RPI和[14C]RPII在感染血链球菌的心脏赘生物中的分布模式不同。[14C]RPI在整个赘生物中均匀分布,而[14C]RPII在赘生物的周边和核心之间显示出浓度递减梯度,比例约为2:1。[14C]RPI向赘生物核心的扩散比[14C]RPII多大约2至4倍。由于在RP 59500中RPI和RPII的注射比例为30:70,赘生物核心中实际的RPI:RPII比例可能在0.8至1.7之间,该比例与这两种成分之间显示的体内协同作用相符。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da7/284476/a6e4286c1736/aac00369-0031-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da7/284476/a6e4286c1736/aac00369-0031-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da7/284476/a6e4286c1736/aac00369-0031-a.jpg

相似文献

1
In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis.链阳性菌素RP 59500的两种成分在实验性心内膜炎心脏赘生物中的体内活性及渗透情况。
Antimicrob Agents Chemother. 1994 Mar;38(3):432-7. doi: 10.1128/AAC.38.3.432.
2
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500.用RP 59500治疗对红霉素敏感或耐药的耐甲氧西林金黄色葡萄球菌引起的实验性心内膜炎。
Antimicrob Agents Chemother. 1995 Jul;39(7):1419-24. doi: 10.1128/AAC.39.7.1419.
3
Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.左氧氟沙星对感染草绿色链球菌或金黄色葡萄球菌的兔实验性主动脉瓣心内膜炎的疗效。
Antimicrob Agents Chemother. 1999 Nov;43(11):2742-6. doi: 10.1128/AAC.43.11.2742.
4
Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus.
J Antimicrob Chemother. 1992 Jul;30 Suppl A:117-22. doi: 10.1093/jac/30.suppl_a.117.
5
Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.对链阳菌素B型抗生素的耐药性对金黄色葡萄球菌所致实验性心内膜炎中RP 59500(奎奴普丁-达福普汀)活性的关键影响。
Antimicrob Agents Chemother. 1995 Feb;39(2):400-5. doi: 10.1128/AAC.39.2.400.
6
Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.替考拉宁在耐甲氧西林金黄色葡萄球菌或万古霉素中介金黄色葡萄球菌所致兔主动脉瓣心内膜炎模型中的疗效
Antimicrob Agents Chemother. 2005 Aug;49(8):3163-5. doi: 10.1128/AAC.49.8.3163-3165.2005.
7
Antistaphylococcal activities of quinupristin/dalfopristin in vitro across platelet-fibrin matrices and in experimental endocarditis.奎奴普丁/达福普汀在体外跨血小板-纤维蛋白基质及实验性心内膜炎中的抗葡萄球菌活性。
J Antimicrob Chemother. 1997 May;39 Suppl A:93-8. doi: 10.1093/jac/39.suppl_1.93.
8
Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics.奎奴普丁-达福普汀与万古霉素联合应用对耐甲氧西林金黄色葡萄球菌的体外抗菌活性及在实验性心内膜炎中的疗效,以及与对大环内酯类、林可酰胺类和链阳菌素B型抗生素的交叉耐药性的关系。
Antimicrob Agents Chemother. 2002 Sep;46(9):3061-4. doi: 10.1128/AAC.46.9.3061-3064.2002.
9
RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.RP 59500对由对红霉素敏感和耐药的同基因草绿色链球菌对引起的实验性心内膜炎的预防作用。
Antimicrob Agents Chemother. 1995 Jul;39(7):1425-9. doi: 10.1128/AAC.39.7.1425.
10
Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus.对链阳性菌素A类抗生素的耐药性对奎奴普丁-达福普汀体外活性及对金黄色葡萄球菌所致实验性心内膜炎的影响。
Antimicrob Agents Chemother. 2000 May;44(5):1168-73. doi: 10.1128/AAC.44.5.1168-1173.2000.

引用本文的文献

1
Diffusion of ofloxacin in the endocarditis vegetation assessed with synchrotron radiation UV fluorescence microspectroscopy.应用同步辐射紫外荧光微光谱法评估氧氟沙星在心内膜炎赘生物中的扩散。
PLoS One. 2011 Apr 29;6(4):e19440. doi: 10.1371/journal.pone.0019440.
2
Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.抗菌药物作为耐甲氧西林金黄色葡萄球菌所致实验性心内膜炎治疗方法的比较
Tex Heart Inst J. 2010;37(4):400-4.
3
Community-associated methicillin-resistant Staphylococcus aureus: reconsideration of therapeutic options.

本文引用的文献

1
Method of reliable determination of minimal lethal antibiotic concentrations.可靠测定最低致死抗生素浓度的方法。
Antimicrob Agents Chemother. 1980 Nov;18(5):699-708. doi: 10.1128/AAC.18.5.699.
2
3H-spiramycin penetration into fibrin vegetations in an experimental model of streptococcal endocarditis.
J Antimicrob Chemother. 1988 Jul;22 Suppl B:127-33. doi: 10.1093/jac/22.supplement_b.127.
3
World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌的全球抗生素耐药性
社区获得性耐甲氧西林金黄色葡萄球菌:治疗选择的重新考量
Curr Infect Dis Rep. 2006 Jan;8(1):23-30. doi: 10.1007/s11908-006-0031-7.
4
Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics.奎奴普丁-达福普汀与万古霉素联合应用对耐甲氧西林金黄色葡萄球菌的体外抗菌活性及在实验性心内膜炎中的疗效,以及与对大环内酯类、林可酰胺类和链阳菌素B型抗生素的交叉耐药性的关系。
Antimicrob Agents Chemother. 2002 Sep;46(9):3061-4. doi: 10.1128/AAC.46.9.3061-3064.2002.
5
Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study.奎奴普丁-达福普汀与庆大霉素联合治疗耐甲氧西林金黄色葡萄球菌:兔心内膜炎实验研究
Antimicrob Agents Chemother. 2002 Jul;46(7):2174-8. doi: 10.1128/AAC.46.7.2174-2178.2002.
6
Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.奎奴普丁-达福普汀与利福平联合用药在体外以及针对对大环内酯-林可酰胺-链阳菌素抗生素具有不同耐药表型的金黄色葡萄球菌菌株所致实验性心内膜炎中的活性。
Antimicrob Agents Chemother. 2001 Apr;45(4):1244-8. doi: 10.1128/AAC.45.4.1244-1248.2001.
7
Therapeutic efficacy of GAR-936, a novel glycylcycline, in a rat model of experimental endocarditis.新型甘氨酰环素GAR-936在大鼠实验性心内膜炎模型中的治疗效果。
Antimicrob Agents Chemother. 2000 Nov;44(11):3022-7. doi: 10.1128/AAC.44.11.3022-3027.2000.
8
Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics.奎奴普丁-达福普汀联合β-内酰胺类药物治疗对大环内酯-林可酰胺-链阳菌素B类抗生素固有耐药的金黄色葡萄球菌所致的实验性心内膜炎。
Antimicrob Agents Chemother. 2000 Jul;44(7):1789-95. doi: 10.1128/AAC.44.7.1789-1795.2000.
9
Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus.对链阳性菌素A类抗生素的耐药性对奎奴普丁-达福普汀体外活性及对金黄色葡萄球菌所致实验性心内膜炎的影响。
Antimicrob Agents Chemother. 2000 May;44(5):1168-73. doi: 10.1128/AAC.44.5.1168-1173.2000.
10
Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.奎奴普丁/达福普汀:用于治疗严重革兰氏阳性菌感染的综述
Drugs. 1999 Dec;58(6):1061-97. doi: 10.2165/00003495-199958060-00008.
Lancet. 1989 Mar 11;1(8637):537-40. doi: 10.1016/s0140-6736(89)90076-7.
4
Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography.
J Infect Dis. 1989 May;159(5):938-44. doi: 10.1093/infdis/159.5.938.
5
Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.低水平万古霉素耐药对替考拉宁和万古霉素治疗粪肠球菌所致实验性心内膜炎疗效的影响。
Antimicrob Agents Chemother. 1991 Aug;35(8):1570-5. doi: 10.1128/AAC.35.8.1570.
6
In vivo antibiotic synergism: contribution of animal models.体内抗生素协同作用:动物模型的贡献
Antimicrob Agents Chemother. 1992 May;36(5):907-12. doi: 10.1128/AAC.36.5.907.
7
In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methods.采用两种方法对新型链阳菌素RP 59500进行体外抗葡萄球菌活性及测试。
Antimicrob Agents Chemother. 1992 Apr;36(4):854-5. doi: 10.1128/AAC.36.4.854.
8
In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a semisynthetic streptogramin, RP 59500.
J Antimicrob Chemother. 1992 Jul;30 Suppl A:95-9. doi: 10.1093/jac/30.suppl_a.95.
9
RP 59500: a proposed mechanism for its bactericidal activity.
J Antimicrob Chemother. 1992 Jul;30 Suppl A:9-14. doi: 10.1093/jac/30.suppl_a.9.
10
Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.新型胃肠外注射半合成链阳菌素RP 59500对具有多种对大环内酯-林可酰胺-链阳菌素类抗生素耐药机制的葡萄球菌的活性。
J Antimicrob Chemother. 1992 Jul;30 Suppl A:67-75. doi: 10.1093/jac/30.suppl_a.67.